Skip to content
Precision for Medicine
Contact Us
Precision Multi-omics and AI services for translational research

Multi-Omics & AI Services

Harness the innovations of today for better precision medicine tomorrow
Lost in translation? Gain clarity with Precision
Design your multi-omic and AI strategy with a team of translational scientists who've helped hundreds of translational programs move forward. Between the scientific question and a confident decision lies a critical gap, the translational chaos, where study plans drift, sample availability is limited, and biological signals risk being lost in translation.
Precision's therapeutics and diagnostic multi-omics development capabilities

Precision is Purpose-Built to Power Modern Therapeutic and Diagnostic Multi-Omic Development

With expertise in today’s most advanced techniques for deeply interrogating samples and understanding patient biology at scale, Precision helps you tackle the most complex global development challenges. Our integrated approach ensures every specimen delivers meaningful insights for therapeutic, diagnostic, and CDx programs.

2000 Therapeutic, diagnostic, and CDx programs supported
5 Specialty Labs across North America and Europe
35M Clinical Samples managed
Integrated AI and multi-omics technologies for stronger early development outcomes

Turn Translational Chaos
into Clinical Clarity

While AI and multi-omics technologies are increasingly accessible, their value depends on a coherent strategy. Without a coordinated multi-omic or AI strategy from the start, teams often encounter avoidable hurdles: 

  • Multiple contracts and mismatched data structures that slow progress 

  • Limited tissue which increases the risk of exhausting precious material 

  • Difficulty comparing findings across platforms or sites 

  • Decision fatigue and wasted financial resources on omics that don’t yield answers

Integrated Omics Across the Translational Research Continuum

Between the scientific question and a confident decision lies a critical gap, the translational chaos, where study plans drift, sample availability is limited, and biological signals risk being lost in translation. Unnecessary tests waste precious time, budget, and biological material. Irrelevant or poorly aligned data creates complexity that slows decisions and increases risk across your program. Precision for Medicine designs focused multi omic strategies that maximize what is finite, so you can accelerate what comes next.

  • Genomics

    Interrogate genomic alterations to guide precision development decisions.
    Apply genomic profiling to identify somatic and germline variants that inform target validation, patient stratification, resistance mechanisms, and companion diagnostic strategies—enabling confident decision‑making from early translational research through late‑phase clinical development.

    Application

    • Whole genome and whole exome sequencing

    • Single cell genomics

    • Amplicon and capture-based enrichment for target characterization

    • Minimal residual disease (MRD) detection

    • Mutation detection, genotyping

    • Vector copy number analysis

    • Biodistribution and shedding (gene therapy)

    • Liquid biopsy via circulating tumor DNA (ctDNA)

     

    Technologies

    • NGS
    • ddPCR
    • qPCR
    • FISH/ISH
    • MSK-IMPACT/ACCESS
    • CLIA-validated custom NGS assays for patient enrollment

  • Epigenomics

    Capture stable regulatory biology to power robust immune monitoring and stratification.
    Deploy bisulfite methylation sequencing to comprehensively measure the methylome and reveal epigenetic regulation underlying cell identity and disease state. Extend insight with Epiontis®, a novel immune monitoring platform using DNA methylation markers uniquely specific to immune cell types, enabling precise, reproducible quantification of immune composition across complex samples and longitudinal studies.

    Application

    • Epigenetic enabled immune profiling

    • Methylation profiling

     

    Technologies

    • Epiontis ID

    • Bisulfite sequencing 

  • Transcriptomics

    Quantify gene expression programs to demonstrate biological response.
    Leverage transcriptomic analyses to measure pathway modulation, immune activation, and pharmacodynamic effects across tissues and blood—linking mechanism of action to clinical outcomes and accelerating proof‑of‑mechanism in early‑phase trials.

    Application

    • Whole transcriptome sequencing

    • Gene expression profiling

      Transgene expression analysis

    • T-cell receptor (TCR) and B-cell receptor (BCR) clonotyping

    • Single Cell Transcriptomics 

     

    Technologies

    • RNASeq

    • Single cell RNASeq

    • NanoString nCounter

    • RT-qPCR

    • RT-ddPCR

    • RNAScope-ISH

  • Proteomics

    Measure functional protein biology to confirm target engagement and pathway impact.
    Utilize proteomic approaches to quantify signaling proteins, cytokines, and biomarker networks that directly reflect drug activity—strengthening translational hypotheses and supporting biomarker‑driven endpoint strategies across development phases.

    Application

    • Whole transcriptome sequencing

    • Gene expression profiling

    • Transgene expression analysis

    • T-cell receptor (TCR) and B-cell receptor (BCR) clonotyping

    • Single Cell Transcriptomics

     

    Technologies

    • RNASeq

    • Single cell RNASeq

    • NanoString nCounter

    • RT-qPCR

    • RT-ddPCR

    • RNAScope-ISH 

  • Cytomics

    Define immune cell composition and function with clinical‑grade precision.
    Apply flow cytometry and cell‑based immune monitoring assays to characterize immune populations, activation states, and functional responses—enabling clear assessment of pharmacodynamic effects, safety signals, and response biology in immunology‑driven programs.

    Application

    • Immune phenotyping

    • Cell classification

    • Pharmacokinetics (PK)

    • Pharmacodynamics (PD)

    • MRD detection

     

    Technologies

    • Flow cytometry (multiplexing)

    • Circulating tumor cell isolation (ApoStream)

    • ElSpot Assays 

  • Spatialomics

    Preserve tissue context to explain response heterogeneity.
    Integrate spatially resolved molecular profiling with histopathology to map gene and protein expression within intact tissue architecture—revealing cell‑cell interactions and microenvironmental drivers that inform indication selection and combination strategies.

    Application

    • Spatially resolved cell classification by gene and protein expression

    • Spatial transcriptomics

    • Spatial proteomics

     

    Technologies

    • mlF

    • Akoya Phenolmager HT (up to 8 markers)

    • PhenoCycler Fusion (60+ markers)

    • Indica Labs

  • Pathomics

    Transform tissue pathology into quantitative, decision‑ready biomarkers.
    Apply advanced histopathology and digital pathology analytics to extract objective, scalable features from tissue architecture and biomarker staining—supporting deep biomarker profiling with quantitative measurements for tissue histopathology

    Application

    • End-to-end digital pathology workflows

    • Quantitative Al-powered pathology

    • Pre-screening for validated downstream output

    • Real-time access to sponsor sample viewing and sharing


    Technologies

    • Scanner suite

    • Tissue processing workflows

    • Al algorithms

    • PathAI-AISight 

  • Genomics analysis of DNA structure for biomarker research
  • Epigenomics analysis represented by a DNA helix illustration
  • Transcriptomics analysis for gene expression biomarker research represented by a DNA helix illustration
  • Proteomics analysis to measure protein biomarkers and pathway activity
  • Cytomics analysis of immune cell populations for translational research
  • Spatialomics tissue analysis showing cellular organization and biomarker expression
  • Pathomics analysis of reticulin-stained tissue morphology
Multi Omics and AI with Precision for Medicine

Designed for Scientists Who Think Beyond the Assay

Streamline your multi‑omic strategy to reduce waste and complexity, so every assay, sample, and dollar delivers value.


Multi‑Omic Analysis, Only What Your Program Needs

Assay strategies designed around discovery, development, and validation goals. No overselling. No unnecessary testing.

Precious Samples from Curated Cohorts in Your Indication

Start confidently with pre‑characterized, ethically sourced biospecimens, ready to ship the same day.

Future‑Proof Alignment for Your Clinical Trial Protocol

Integrated lab and trial capabilities ensure assays perform in real‑world clinical settings, because they are designed with downstream execution in mind.

Download the multi-omics ebook

Faster, Leaner Science Built Around Your Program Needs

ApoStream® recovers viable circulating tumor cells from liquid biopsy, preserving morphology and enabling downstream multi-omic analysis when tissue is scarce.  

Learn more about ApoStream®
Case Study

Therapeutic Target Analysis in CTCs Isolated from NSCLC Patients Using ApoStream®

Read More
Therapeutic Target Analysis in CTCs Isolated from NSCLC Patients Using ApoStream®

Related Resources

Experiences, tips, and perspectives from experts on the front lines of research. 

 All Resources
  • Brochure

    Translational and Biomarker Sciences: Enabling Breakthroughs

    Download Brochure
    Translational and Biomarker Sciences: Enabling Breakthroughs
  • Webinar

    AI & Multi-Omics for Translational Research

    Watch Webinar
    AI & Multi-Omics for Translational Research
  • Infographic

    Comprehensive Multi-Omics Approach to Support Biomarker Programs

    Download Infographic
    Comprehensive Multi-Omics Approach to Support Biomarker Programs

World class standards & certifications

  • FDA regulatory adherence
  • College of American Pathologists accreditation logo
  • Clinical Laboratory Improvement Amendments certification logo
  • Medical IRB and IEC review compliance
  • Good Clinical Practices Certification
  • Good Laboratory Practice Certification

Additional insights on AI & Multi-Omics

Explore more insights
Read: Lost in Translation: Turning Multi-omic Chaos into Clinical Clarity Lost in Translation: Turning Multi-omic Chaos into Clinical Clarity

Translational Research - Lab Services

Lost in Translation: Turning Multi-omic Chaos into Clinical Clarity

|
    has third author: false, (SizeLimitingPyMap: {main={hs_id=159488778872, hs_child_table_id=0, hs_updated_at=1744653337128, hs_published_at=1784230314171, description=Visionary leader with decades of distinguished biotechnology and clinical translational research experience. Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dedicated and committed to improving the lives of patients with debilitating diseases., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Darren%20Davis.webp',altText='Darren Davis',fileId=165891429693}, linkedin=https://www.linkedin.com/in/drdarrendavis, team=[{id=163072475009, name='Translational Sciences Leadership'}], hs_name=, hs_path=, lastname=Davis, PhD, hs_initial_published_at=1775839468505, hs_created_at=1709645745103, hs_is_edited=false, hs_deleted_at=0, name=Darren, job=Senior Vice President, Translational Sciences, slug=darren-davis, email=, hs_updated_by_user_id=51739740}, second={hs_id=167888548278, hs_child_table_id=0, hs_updated_at=1722451546286, hs_published_at=1784230314171, description=Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Deb%20Phippard.webp',altText='Deb Phippard',fileId=165892372605}, linkedin=https://www.linkedin.com/in/deb-phippard-103b54, team=[{id=163072475009, name='Translational Sciences Leadership'}], hs_name=, hs_path=, lastname=Phippard, PhD, hs_initial_published_at=1716194887110, hs_created_by_user_id=2737751, hs_created_at=1716194842710, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job=Chief Scientific Officer, slug=deborah-phippard-translational-sciences, email=, hs_updated_by_user_id=51739740}, third={hs_id=159488778886, hs_child_table_id=0, hs_updated_at=1763657611624, hs_published_at=1784230314171, description=Robert Snyder, PhD, is a seasoned expert with a 20-year track record in genomics, specializing in in vitro diagnostic assay development and bioinformatics. Committed to advancing medical science, he is proficient in regulatory V&V study designs and understands the nuances of orthogonal methods. A collaborative partner in biomedical development, Dr. Snyder champions the critical transition of biospecimens from benchtop to bedside., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Robert%20Snyder.webp',altText='Robert Snyder',fileId=165892444501}, linkedin=https://www.linkedin.com/in/robert-snyder-ph-d-9b67b035, hs_name=, hs_path=, lastname=Snyder, PhD, hs_initial_published_at=1775839468505, hs_created_at=1709645745117, hs_is_edited=false, hs_deleted_at=0, name=Robert, job=, slug=robert-snyder, email=, hs_updated_by_user_id=51739740}})
  • Darren D. avatar Deborah P. avatar Robert S. avatar

  • Darren D.

    Deborah P.

    Robert S.
Read: Reflect on 20 Years of Cancer Research with MIRROR Biospecimens Reflect on 20 Years of Cancer Research with MIRROR Biospecimens

Translational Research - Biospecimens

Reflect on 20 Years of Cancer Research with MIRROR Biospecimens

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=199448088864, hs_child_table_id=0, hs_updated_at=1762810484868, hs_published_at=1784230314171, avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Kaylee%20Mueller.png',altText='Kaylee Mueller',fileId=199456336149}, lastname=Mueller, hs_initial_published_at=1762810487482, hs_created_by_user_id=26433386, hs_created_at=1762810467146, hs_is_edited=false, hs_deleted_at=0, name=Kaylee, slug=kaylee-mueller, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Kaylee Mueller avatar

    Kaylee Mueller
Read: How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development

Translational Research - Biomarkers - Oncology

How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1754641583843, hs_published_at=1784230314171, description=Rob Maiale is a marketing strategist and creative technologist with 17 years of experience turning complex ideas into growth. He currently leads content strategy, where he transforms insights from Precision experts into market-shaping narratives that drive the advancement of next-generation therapies.  Rob’s career spans journalism, advertising, and brand storytelling, with a through-line of making the meaningful memorable. His work blends creative strategy with emerging AI tools to help Precision stay ahead of the curve—and above the noise., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/rob.png',altText='rob',fileId=194099000843}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_initial_published_at=1775839468505, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, position=Associate Director, Digital Content & Inbound Marketing, job=, slug=rob-maiale, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale
Loading...